https://www.lymedisease.org/cdc-disclaimer-lyme-disease/?fbclid=IwAR375jSbiOuDQEeJE7JodnxwVPZI3sHiBY2DOO2A0cz6SH6Y3MNpSzQd_xg
CDC Agrees to Add Disclaimer to Lyme Disease Case Definition (this is a plus)
he Centers for Disease Control and Prevention (CDC) has agreed to add a disclaimer to the surveillance case definition for Lyme disease.
The disclaimer says that the definition is “not intended to be used by healthcare providers for making a clinical diagnosis or determining how to meet an individual patient’s health needs.”
According to a July 16 letter from Lyle Peterson, MD, Director of the CDC Division of Vector-Borne Diseases, this change is being implemented on “all individual case definition pages, including the 2017 Lyme disease case definition page.”
This action followed an Information Quality Request for Correction complaint filed by the Patient Centered Care Advocacy Group on May 20.
According to the complaint, a disclaimer is needed because many healthcare providers incorrectly rely on the surveillance case definition of Lyme disease for diagnosis.
This results in large numbers of patients who are misdiagnosed and denied medically necessary treatment and insurance coverage. Lack of early diagnosis prevents patients from getting early treatment that improves the likelihood they will recover completely.
Surveillance definition
The CDC disclaimer states:
“A surveillance case definition is a set of uniform criteria used to define a disease for public health surveillance. Surveillance case definitions enable public health officials to classify and count cases consistently across reporting jurisdictions. Surveillance case definitions are not intended to be used by healthcare providers for making a clinical diagnosis or determining how to meet an individual patient’s health needs.”
According to the case definition for Lyme disease, most patients must either have an erythema migrans rash (EM, also known as a bull’s-eye rash) or test positive on a two-tier blood test according to a narrow threshold.
Yet many patients never get a rash, and a systematic meta-analysis of published data shows the mean sensitivity of two-tier test to be only 35.4% in the acute stage and 64.5% in the convalescent stage, with an overall sensitivity of 59.5%.
According to the complaint, the unreliability of the two-tier test is compounded by widespread misconception by healthcare providers and insurers that patients must test positive according to the surveillance criteria to confirm they have a legitimate case of Lyme disease.
Go to this link to read request for connection and CDC response:
https://www.lymedisease.org/cdc-disclaimer-lyme-disease/?fbclid=IwAR375jSbiOuDQEeJE7JodnxwVPZI3sHiBY2DOO2A0cz6SH6Y3MNpSzQd_xg
--------------------------------------
Dear RM Agents and Readers,
Do You ever feel like they are doing just enough to avoid a revolution started by those that have and still suffer from Lyme and related Co infections? As a tea kettle becomes ready to be used to steep your tea it begins to make a loud noise. Yet, if it didn't have the spout it would explode because there would be no release.
Glad this has happened but overall think the occurrences of the last few months and total disregard for human welfare for the last 40 years are just BS. Hopefully, it will blow up in their face, the whole nine yards of the insanity they have place on not only the American People but the world at large.
Think this is just a release so there is no explosion; personally I think it is time for more than just a release. Hopefully, others who are in more of an influencing position will see this for what it really is. An attempt to buy people with Lyme disease off at the cost of everyone involved. Just shoveling more crap our way!
https://www.lymedisease.org/cdc-disclaimer-lyme-disease/?fbclid=IwAR375jSbiOuDQEeJE7JodnxwVPZI3sHiBY2DOO2A0cz6SH6Y3MNpSzQd_xg
Many Blessings,
CrystalRiver
